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Sirtuin 3 (SIRT3), an important regulator of energy metabolism and lipid oxidation, is
induced in fasted liver mitochondria and implicated in metabolic syndrome. In fasted liver,
SIRT3-mediated increases in substrate flux depend on oxidative phosphorylation
(OXPHOS), but precisely how OXPHOS meets the challenge of increased substrate
oxidation in fasted liver remains unclear. Here, we show that liver mitochondria in fasting
mice adapt to the demand of increased substrate oxidation by increasing their OXPHOS
efficiency. In response to cAMP signaling, SIRT3 deacetylated and activated leucine-rich
protein 130 (LRP130; official symbol, LRPPRC), promoting a mitochondrial transcriptional
program that enhanced hepatic OXPHOS. Using mass spectrometry, we identified SIRT3-
regulated lysine residues in LRP130 that generated a lysine-to-arginine (KR) mutant of
LRP130 that mimics deacetylated protein. Compared with wild-type LRP130 protein,
expression of the KR mutant increased mitochondrial transcription and OXPHOS in vitro.
Indeed, even when SIRT3 activity was abolished, activation of mitochondrial transcription
and OXPHOS by the KR mutant remained robust, further highlighting the contribution of
LRP130 deacetylation to increased OXPHOS in fasted liver. These data establish a link
between nutrient sensing and mitochondrial transcription that regulates OXPHOS in fasted
liver and may explain how fasted liver adapts to increased substrate oxidation.
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Sirtuin 3 (SIRT3), an important regulator of energy metabolism and lipid oxidation, is induced in fasted liver 
mitochondria and implicated in metabolic syndrome. In fasted liver, SIRT3-mediated increases in substrate flux 
depend on oxidative phosphorylation (OXPHOS), but precisely how OXPHOS meets the challenge of increased 
substrate oxidation in fasted liver remains unclear. Here, we show that liver mitochondria in fasting mice adapt 
to the demand of increased substrate oxidation by increasing their OXPHOS efficiency. In response to cAMP 
signaling, SIRT3 deacetylated and activated leucine-rich protein 130 (LRP130; official symbol, LRPPRC), 
promoting a mitochondrial transcriptional program that enhanced hepatic OXPHOS. Using mass spectrom-
etry, we identified SIRT3-regulated lysine residues in LRP130 that generated a lysine-to-arginine (KR) mutant 
of LRP130 that mimics deacetylated protein. Compared with wild-type LRP130 protein, expression of the KR 
mutant increased mitochondrial transcription and OXPHOS in vitro. Indeed, even when SIRT3 activity was 
abolished, activation of mitochondrial transcription and OXPHOS by the KR mutant remained robust, fur-
ther highlighting the contribution of LRP130 deacetylation to increased OXPHOS in fasted liver. These data 
establish a link between nutrient sensing and mitochondrial transcription that regulates OXPHOS in fasted 
liver and may explain how fasted liver adapts to increased substrate oxidation.
Introduction
In normal fasted liver, an increase in ATP-dependent process-
es (such as gluconeogenesis and ureagenesis) and ketogenesis 
requires substrate oxidation, specifically β-oxidation of fatty 
acids. Presumably, oxidative phosphorylation (OXPHOS) must 
match this increased need for ATP during fasting. Precisely how 
coordination of this kind occurs in vivo remains an open ques-
tion. Addressing this question is important, as several studies 
imply that a mismatch between substrate oxidation and OXPHOS 
may sustain or exacerbate metabolic disease (1–3). In principle, an 
increase in mitochondrial content (biogenesis) and/or OXPHOS 
efficiency (OXPHOS activity per mitochondrion) could accom-
modate increased ATP requirements in fasted liver. In terms of 
regulatory control, sirtuin 3 (SIRT3), a mitochondrial sensor of 
nutrients, is an attractive candidate, since SIRT3 influences both 
substrate oxidation and OXPHOS.
SIRT3 is a mitochondrial NAD+-dependent deacetylase that 
senses nutrient deprivation (4). Upon fasting, SIRT3 protein 
is induced in liver, where it activates enzyme systems involved 
in fatty acid oxidation and ketogenesis (5, 6). Both long-chain 
acyl-CoA dehydrogenase (ACADL; also known as LCAD) and 
3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) are 
deacetylated by SIRT3, culminating in enhanced β-oxidation 
of fatty acids and ketogenesis, respectively (5, 6). In cell culture, 
SIRT3 influences energy metabolism; however, different mecha-
nisms have been proposed for various cell types (7–10). Never-
theless, whether and how SIRT3 influences energy metabolism 
in vivo, and under what biological conditions, remains an open 
question. Given that SIRT3 is implicated in metabolic syndrome 
(10, 11), resolving this question might explain how defective 
mitochondria emerge in metabolic disease.
Mitochondrial transcription potently inf luences energy 
metabolism (12). The basal transcription machinery of mito-
chondria consists of mitochondrial transcription factor B2 
(TFB2M) and mitochondrial RNA polymerase (POLRMT) 
(13–15). The basal machinery is activated by mitochondrial 
transcription factor A (TFAM), which also participates in mito-
chondrial DNA (mtDNA) packaging and replication (16–21). 
Recently, leucine-rich protein 130 (LRP130; official symbol, LRP-
PRC [leucine-rich PPR motif–containing]), a protein implicated 
in Leigh syndrome (22, 23), was found to stimulate transcrip-
tion of the core mitochondrial machinery and induce mitochon-
drially encoded transcripts (12), including 13 polypeptides that 
encode core subunits of the electron transport chain (24, 25). 
Independent of mitochondrial biogenesis, LRP130 induced 
mitochondrially encoded gene expression, culminating in 
increased OXPHOS efficiency (i.e., greater OXPHOS per mito-
chondrion). Additionally, cells and liver replete with LRP130 
had greater β-oxidation of fatty acid (12), which implies that 
increased OXPHOS facilitates greater substrate oxidation. If 
the transcription machinery of mitochondria is activated by 
nutrient deprivation to enhance energy metabolism, this might 
explain how fasted liver increases its substrate oxidation, a pro-
cess critical for ATP-dependent pathways, such as gluconeogen-
esis and ureagenesis, as well as for ketogenesis.
Here, we investigated coordination between nutrient depriva-
tion and OXPHOS activity, considering mitochondrial biogen-
esis and/or OXPHOS efficiency as potential mechanisms. We 
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found that normal fasted liver used mitochondria with greater 
OXPHOS efficiency, rather than increasing mitochondrial mass. 
Greater OXPHOS efficiency was achieved by increasing mito-
chondrial transcription, regulatory control that was dependent 
on SIRT3 and LRP130. In fasted liver, SIRT3 deacetylated and 
activated LRP130, which stimulated mitochondrial transcription 
to promote OXPHOS. This process was triggered by glucagon/
cAMP signaling. We propose that the transcription machinery of 
mitochondria senses nutrients via SIRT3, permitting augmenta-
tion of OXPHOS.
Results
In liver, fasting coordinately induces mitochondrially encoded transcripts 
and OXPHOS capacity. Fasted liver is notable for ATP-consum-
ing processes, and is thus dependent on OXPHOS. Given that 
induction of mitochondrially encoded transcripts stimulates 
OXPHOS, we wondered whether mitochondrially encoded tran-
scripts and OXPHOS are coordinately induced in fasted liver of 
C57BL/6 mice. After fasting for 24 hours, mouse liver showed 
modestly increased mitochondrially encoded transcripts and 
OXPHOS capacity (Figure 1, A and C). Indicative of a normal 
fasted response, mRNA of Pepck and G6p, enzymes involved in 
gluconeogenesis, was induced, whereas that of Scd1 and Fasn, 
enzymes involved in lipogenesis, was attenuated (Figure 1B). 
Interestingly, the increase in complex IV activity that we observed 
(Figure 1C) paralleled that reported by another group; however, 
alterations in mitochondrial content were not explored in the 
previous report (26).
Conceivably, changes in mitochondrially encoded transcripts 
and OXPHOS might be explained by increased mitochondrial 
content. We therefore quantified mitochondrial biogenesis using 
complementary genetic, biochemical, and protein assessments. 
While mRNA for Pgc1a, a potent regulator of mitochondrial bio-
genesis, was induced, there was no induction of Tfam, Polrmt, 
and Tfb2m, which comprise the basal transcription machinery of 
mitochondria, or of Lrp130, which stimulates the core machinery 
(Figure 1B). Because genes comprising the basal transcription 
machinery are induced during mitochondrial biogenesis, their 
lack of induction were indicative of stable mitochondrial content. 
mtDNA content was unchanged (Figure 1D), in support of unal-
tered mitochondrial mass. Because the activity of citrate synthase 
proved indistinguishable in isolated mitochondria (Figure 1E), its 
Figure 1
Fasting coordinately induces mitochondrially encoded transcripts and OXPHOS in liver. (A) Hepatic gene expression of mitochondrially encoded 
transcripts in 24-hour fasted or fed C57BL/6 mice (n = 3). (B) Expression of genes that regulate mitochondrial biogenesis, mitochondrial transcrip-
tion, lipogenesis, and gluconeogenesis (n = 3). (C) Complex activity of mitochondria isolated from liver of 24-hour fasted or fed C57BL/6 mice 
(n = 3). CI–CV, complexes I–V; CS, citrate synthase. (D) Biochemical assessment of mitochondrial content using citrate synthase activity in whole 
liver homogenate (n = 3). (E) Genetic assessment of mitochondrial content using mtDNA content (n = 3). (F) Assessment of mitochondrial content 
by immunoblotting citrate synthase protein in whole liver homogenate (n = 3–4). Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 2-way 
ANOVA, with (B and C) or without (A) Bonferroni post-test, or 2-tailed unpaired Student’s t test (D and E).
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activity in whole-liver homogenate permitted biochemical assess-
ment of mitochondrial content. In agreement with genetic data, 
the activity and protein level for citrate synthase were unchanged 
(Figure 1, E and F), indicative of stable mitochondrial content 
regardless of feeding status. Hence, induction of Pgc1a was not 
associated with altered mitochondrial content in fasted liver. As 
previously reported in other systems (27, 28), these data imply that 
a certain threshold effect of PGC-1α coactivator activity is neces-
sary to induce mitochondrial biogenesis.
Next, we sought to understand which nutrient signaling pathway 
influences mitochondrially encoded gene expression. Broadly, the 
fasting response is notable for a decline in insulin and an increase 
in glucagon, the latter of which activates intracellular cAMP signal-
ing. Using cultured primary hepatocytes, we evaluated these possi-
bilities. Withdrawal of insulin had no effect on the fasting-respon-
sive genes Pepck and G6p or on mitochondrially encoded genes 
(Figure 2, A and C). As reported by others, glucagon induced both 
Pepck and G6p (Figure 2C). Interestingly, mitochondrially encoded 
genes were also induced, while many nuclear encoded ETC genes 
were unaffected (Figure 2, A and B). Forskolin, which increases 
intracellular cAMP levels, induced mitochondrially encoded genes 
as well (Supplemental Figure 1; supplemental material available 
online with this article; doi:10.1172/JCI69413DS1), which indi-
cates that the cAMP pathway governed by glucagon is likely respon-
sible. Even in Pgc1a null primary hepatocytes, glucagon was still 
sufficient to induce mitochondrially encoded genes, although the 
response was modestly blunted (Supplemental Figure 1, C and D). 
These data further support the observation that de novo biogen-
esis is not required. Induction of mitochondrially encoded genes 
was accompanied by an increase in mitochondrially encoded pro-
teins (Figure 2, D–F). Even so, in both primary mouse hepatocytes 
and mouse liver, gene expression was largely unchanged for several 
nuclear encoded ETC subunits (Figure 2B and Figure 3A). Several 
nuclear encoded ETC proteins, however, were increased in fast-
ing liver mitochondria (Figure 3, B and C), which indicates that 
they were modestly stabilized (or more efficiently translated) in 
the fasted state. Overall, these data are suggestive of a coordinated 
response that facilitates enhanced OXPHOS. Importantly, mito-
chondrially encoded proteins, which are central to the process, are 
regulated at the level of gene expression.
Finally, we used a different mouse strain to test the generality of 
the response. Similar to C57BL/6 mice, mitochondrially encod-
ed genes were increased in 129S mice (Supplemental Figure 2), 
although the induction of Pepck, G6p and other genes was less 
Figure 2
Glucagon induces mitochondrially encoded genes and proteins. (A) Neither insulin/
dexamethasone (Insulin+Dex) nor their withdrawal (Vehicle) had an effect on mito-
chondrially encoded gene expression; however, glucagon induced mitochondrially 
encoded gene expression. (B) Effect of glucagon on several nuclear encoded ETC 
subunits. (C) Effect of glucagon on fasting-responsive genes and regulators of mito-
chondrial content and function. (D) [35S]-methionine labeling of cytoplasmic proteins 
(left 2 lanes) and mitochondrially encoded translation products, which were evident 
after inhibition of cytoplasmic translation with cycloheximide (CHX) (middle 6 lanes). 
Consistent with mitochondrial translation products, chloramphenicol (CAP) blocked 
their translation (right 2 lanes). GCG, glucagon. (E) Coomassie brilliant blue stain-
ing of the [35S]-labeled gel, showing equal protein loading. (F) Quantification of 
mitochondrially encoded [35S]-labeled proteins by scintillation courting (n = 3). Data 
are mean ± SEM. **P < 0.01, ***P < 0.001, 2-way ANOVA, with (B and C) or without 
(A) Bonferroni post-test, or 2-tailed unpaired Student’s t test (F).
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robust. Similar to C57BL/6 mice, induction of mitochondrially 
encoded genes in 129S mice was not attributable to alterations in 
mitochondrial content (Supplemental Figure 2).
These observations indicated that the fasting response is accom-
panied by increases in mitochondrially encoded transcripts and 
OXPHOS, independent of de novo mitochondrial biogenesis. 
Given that increased mitochondrially encoded gene expression 
enhances OXPHOS (12), these data might imply that induction of 
mitochondrially encoded genes in cooperation with nuclear encod-
ed subunits increases the capacity for OXPHOS in fasted liver.
SIRT3 is necessary and sufficient for fasting-mediated induction of mito-
chondrially encoded transcripts and OXPHOS. By sensing the level of 
Figure 3
Glucagon-mediated induction of mitochondrially encoded genes requires SIRT3. (A) Fasted mouse liver showed no change in gene expression 
for several nuclear encoded ETC genes (n = 3–4). (B) Representative immunoblot of several nuclear encoded ETC subunits. Freshly isolated 
mitochondria were alkaline extracted with carbonate buffer, permitting assessment of the membrane fraction (Pellet) or soluble fraction. (C) 
Quantification of the several nuclear encoded ETC subunits (n = 3–4). (D–H) In Sirt3 knockout primary hepatocytes, glucagon-mediated induction 
of fasting-responsive genes was unaltered (D); however, induction of mitochondrially encoded gene expression was completely abrogated (E; 
n = 3) and no longer accompanied by increased mitochondrially encoded translation products (F and H). (G) Coomassie brilliant blue staining 
of [35S]-labeled gel, showing equal protein loading. Similar results were obtained using nicotinamide (see Supplemental Figure 1, E and F). Data 
are mean ± SEM, except in C (mean ± SD). *P < 0.05, **P < 0.01, ***P < 0.001, 2-way ANOVA with Bonferroni post-test (A, D, and E) or 2-tailed 
unpaired Student’s t test (C and H).
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Figure 4
In liver, SIRT3 is necessary and sufficient for fasting-mediated induction of mitochondrial encoded transcripts and OXPHOS. (A) Hepatic gene 
expression of mitochondrially encoded transcripts in 24-hour fasted Sirt3 KO mice (129S background) (n = 3). (B) Expression of genes that regulate 
mitochondrial biogenesis, mitochondrial transcription, lipogenesis, and gluconeogenesis in Sirt3 KO liver (n = 3). (C) Complex activity from liver 
of 24-hour fasted or fed Sirt3 KO mice (n = 3). (D) Genetic assessment of mitochondrial content using mtDNA content (n = 3). (E) Biochemical 
assessment of mitochondrial content using citrate synthase activity in whole liver homogenate (n = 3). (F) Assessment of mitochondrial content by 
immunoblotting citrate synthase protein in whole liver homogenate (n = 3). (G and H) Expression of (G) mitochondrially encoded transcripts and (H) 
genes that regulate mitochondrial biogenesis and mitochondrial transcription in H2.35 hepatoma cells stably expressing LacZ or SIRT3 (n = 3). (I) 
Immunoblot showing expression of ectopically expressed myc-tagged SIRT3 protein. (J) Using a Clark-type oxygen electrode, cellular respiration — 
basal, proton leak, and maximal respiration (FCCP) — was assessed in H2.35 hepatoma cells stably expressing LacZ or SIRT3. (n = 4). See Supple-
mental Figure 6 for representative oxygen consumption curves. (K) Fluorescent assessment of mitochondrial content using MitoTracker Green FM 
(n = 3). (L) Genetic assessment of mitochondrial content using mtDNA content (n = 3). Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 
2-way ANOVA, with (A and G) or without (B and H) Bonferroni post-test, or 2-tailed unpaired Student’s t test (C–E and J–L).
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cellular NAD+, sirtuins are important sensors of nutrient depriva-
tion. To globally assess this, we treated primary hepatocytes with 
nicotinamide, which inhibits NAD+-dependent sirtuin activity, 
and evaluated the response to glucagon. Nicotinamide had no 
effect on the fasting-responsive genes Pepck and G6p (Supplemen-
tal Figure 1E). In contrast, nicotinamide abrogated induction of 
mitochondrially encoded genes (Supplemental Figure 1F), which 
suggests that a NAD+-dependent pathway is necessary for their 
induction. These data indicate that a NAD+-dependent pathway, 
possibly via a sirtuin, mediates induction of mitochondrially 
encoded genes in the fasted response. SIRT3 protein is a sensor 
of nutrient deprivation that is induced in fasted liver mitochon-
dria (5, 29). Moreover, prior studies in cell lines indicate that it 
influences cellular respiration (7–9); thus, SIRT3 might coordinate 
changes in energy metabolism with the fasted response. For these 
reasons, SIRT3 protein was an attractive candidate in the control 
of mitochondrially encoded gene expression and concomitant 
OXPHOS in fasted liver. We therefore challenged Sirt3 KO primary 
hepatocytes with glucagon. Similar to nicotinamide-treated pri-
mary hepatocytes, glucagon stimulated several fasting-responsive 
genes in the Sirt3 KO primary hepatocytes, but failed to induce 
mitochondrially encoded gene expression or mitochondrially 
encoded translation products (Figure 3, D–H).
Given that SIRT3 is implicated in energy metabolism in cell lines 
and is induced in fasted liver, we evaluated the fasting response in 
Sirt3 KO mouse liver. Neither mitochondrially encoded transcripts 
nor OXPHOS were induced in fasted Sirt3 KO liver, despite a slight 
increase in mitochondrial content (Figure 4, A–F). Again, there was 
no change in nuclear encoded ETC subunits (Supplemental Fig-
ure 3). Additionally, we depleted SIRT3 in C57BL/6 mouse liver 
using shRNA targeting Sirt3 (Supplemental Figure 4A). Again, 
both mitochondrially encoded gene expression and induction of 
OXPHOS were impaired, independent of mitochondrial content 
(Supplemental Figure 4). Moreover, SIRT3 knockdown did not 
influence the general fasting response, as these mice proved indis-
tinguishable from wild-type C57BL/6 mice (compare Figure 1B 
and Supplemental Figure 4D). These findings in 2 mouse models 
of SIRT3 deficiency argue that SIRT3 is required for induction of 
mitochondrially encoded transcripts and OXPHOS in fasted liver.
Next, we evaluated whether SIRT3 is sufficient to induce mito-
chondrially encoded gene expression. SIRT3 was ectopically 
expressed in mouse liver using adenovirus encoding Sirt3 (Sup-
plemental Figure 5, A–E). To minimize hormonal influences and 
genetic variations due to feeding status, food was briefly removed 
for 3 hours to clear the gastrointestinal tract of residual food. 
Brief food deprivation did not alter mitochondrially encoded tran-
scripts or SIRT3 protein (data not shown), the latter of which is 
induced only after a longer fast (5). Even in the absence of potent 
fasting cues, ectopic expression of SIRT3 modestly induced mito-
chondrially encoded gene expression. Induction of mitochondri-
ally encoded genes was not associated with alterations in mito-
chondrial content (Supplemental Figure 5, D and E). This action 
Figure 5
SIRT3 induces mitochondrially encoded genes by stimulating mitochondrial transcription. (A) Metabolic labeling with 4sU. This method quantifies 
de novo transcripts, permitting assessment of mitochondrial transcription in whole cells. It can also be used to monitor transcript degradation. (B) 
Transcription of Sirt3, driven by the viral CMV promoter, was induced in cells replete with SIRT3, whereas transcription of several housekeeping 
genes was unchanged (n = 3). (C) Cells stably expressing SIRT3 exhibited increased mitochondrial transcription (n = 3). (D) Uridine was used to 
chase the 4sU label and assess transcript half-life. Half-lives of mitochondrial transcripts in H2.35 hepatoma cells stably expressing SIRT3 were 
unchanged. Data are mean ± SEM. ****P < 0.0001, 2-way ANOVA, with (B) or without (C) Bonferroni post-test.
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proved cell autonomous, as mitochondrially encoded gene expres-
sion was also induced in H2.35 murine hepatoma cells stably 
expressing SIRT3 as well as in primary hepatocytes transduced for 
36 hours with Sirt3 adenovirus (Figure 4, G–L, and Supplemental 
Figure 5, F and G). Unlike primary hepatocytes, H2.35 hepatoma 
cells stably transduced with SIRT3 required supplementation with 
500 μM NAD+, a cofactor for SIRT3. Even though mechanisms 
involving NAD+ uptake by mitochondria remain controversial, 
extracellular NAD+ does increase the concentration of NAD+ with-
in mitochondria (30, 31). To make fair comparisons, LacZ H2.35 
control cells were treated likewise.
Next, we evaluated OXPHOS in H2.35 cells stably expressing 
SIRT3. In cells replete with SIRT3, maximal cellular respiration 
was modestly induced about 12%, while basal respiration and 
proton leak were unchanged (Figure 4J). Increased respiratory 
capacity was independent of de novo mitochondrial biogenesis 
(Figure 4, K and L). Using galactose, a fuel in which very little 
ATP is derived from glycolysis, maximal cellular respiration was 
increased about 37% (Supplemental Figure 6). These data imply 
that, after a bout of fasting, induction of SIRT3 is both necessary 
and sufficient for the induction of mitochondrially encoded tran-
scripts and OXPHOS.
SIRT3 activates mitochondrial transcription and promotes OXPHOS via 
LRP130. Induction of mitochondrially encoded transcripts stimu-
lates OXPHOS (12). Mitochondrially encoded gene expression is 
the summation of transcription and degradation. Presumably, 
SIRT3 influenced one or both of these pathways. Transcription 
and RNA degradation can be assessed by metabolic labeling, using 
pulse and pulse-chase experiments, respectively (Figure 5A). To 
assess mitochondrial transcription, we pulse-labeled cells with 
4-thiouridine (4sU), a naturally occurring analog of UTP. After 
isolating RNA, 4sU-labeled transcripts were biotinylated, recov-
ered on streptavidin beads, and quantified by quantitative PCR 
(qPCR). Because labeling is brief and much shorter than the half-
life of most mitochondrially encoded transcripts, this method 
allows for quantitative assessment of transcription (32–34). Driv-
en by a powerful CMV promoter, Sirt3 mRNA served as a positive 
control for transcription (Figure 5B). Several housekeeping genes 
were unchanged (Figure 5B), indicative of specific transcription. 
Ectopic expression of SIRT3 induced mitochondrial transcription, 
but failed to influence transcript degradation (Figure 5, C and D). 
Akin to transcription in the nucleus, these data support the gen-
eral observation that changes in gene expression are largely driv-
en by transcription (33). Overall, these data indicate that SIRT3 
induces mitochondrially encoded gene expression by stimulating 
mitochondrial transcription. Given that mitochondrial mass and 
mtDNA content were stable (Figure 4 and Supplemental Figure 5), 
induction by SIRT3 signified increased transcription per mito-
chondrial genome.
Next, we explored the mechanism by which SIRT3 influences 
mitochondrial transcription and OXPHOS. Independent of 
de novo mitochondrial biogenesis, it was previously reported 
that LRP130 interacts with POLRMT, culminating in enhanced 
mitochondrial transcription and attendant OXPHOS (12). We 
therefore wondered whether SIRT3 activates mitochondrial tran-
scription and OXPHOS via LRP130. To test this, we ectopically 
expressed SIRT3 in cells deficient for LRP130. Using a previously 
validated RNAi (12, 35, 36), LRP130 knockdown in H2.35 cells was 
greater than 85% at the mRNA and protein levels (Figure 6, A and 
B). As previously reported (12, 35, 36), mitochondrially encoded 
transcripts were globally attenuated in LRP130-deficient cells, 
whereas genes involved in mitochondrial biogenesis and mito-
chondrial transcription were unchanged (Figure 6, C and D). In 
cells deficient for LRP130, ectopically expressed SIRT3 failed to 
induce either mitochondrially encoded transcripts or OXPHOS 
(Figure 6, C and E). In contrast, OXPHOS was increased in con-
trol shRNA LacZ cells replete with SIRT3 protein (Supplemental 
Figure 6), an induction similar to that shown in Figure 4J. Effects 
on mitochondrial transcription and energy metabolism were not 
caused by altered mitochondrial content, as genetic and fluores-
cent markers of mitochondrial content were unperturbed (Figure 
6, F and G). Finally, effects on mitochondrial transcription and 
energy metabolism were not caused by perturbation of TFB2M 
or POLRMT, which collectively comprise the basal transcription 
machinery. Specifically, cells deficient or replete with LRP130 pro-
tein did not alter POLRMT or TFB2M protein levels (Supplemen-
tal Figure 7, A and B).
Next, we fasted mice in which Lrp130 was ablated in liver. To 
achieve liver-specific Lrp130 in adult mice, animals harboring 
floxed Lrp130 alleles were injected via tail vein with adeno-
associated virus containing a vector coding for liver-specific cre 
recombinase (AAV-Cre), yielding liver-specific LRP130 KO mice 
(referred to herein as LRP130 LKO mice; Figure 6, H and I). After 
a 24-hour fast, mitochondrially encoded genes were induced in 
wild-type mice, but not LRP130 LKO mice (Figure 6J), which 
indicates that LRP130 is required for induction of mitochondri-
ally encoded genes in fasted liver. As previously reported, mito-
chondrially encoded gene expression was globally decreased in 
LRP130 LKO liver (Figure 6J). Details of the Lrp130flox/flox allele 
are shown in Supplemental Figure 7C. We additionally ectopi-
cally expressed SIRT3 in Lrp130 KO primary hepatocytes. The 
ability of SIRT3 to induce mitochondrially encoded genes was 
abrogated in Lrp130 KO hepatocytes (Supplemental Figure 8). 
Finally, we evaluated fatty acid in H2.35 cells stably express-
ing SIRT3 but deficient for LRP130, since fatty acid oxidation 
depends on OXPHOS. Antimycin A (which inhibits electron 
transfer and, hence, OXPHOS) served as a positive control. In 
the absence of LRP130, fatty acid oxidation was significantly 
impaired (Supplemental Figure 8), which suggests that LRP130 
Figure 6
SIRT3-mediated induction of mitochondrial transcription requires 
LRP130. (A–D) Gene expression of Lrp130 and Sirt3 (A), representa-
tive immunoblot of LRP130 and SIRT3 (B), gene expression of mito-
chondrially encoded transcripts (C), and expression of genes that 
regulate mitochondrial biogenesis and mitochondrial transcription (D) 
in H2.35 hepatoma cells replete with LacZ or SIRT3, superimposed 
with control (shCtrl) or Lrp130 knockdown (shLRP130) (n = 3). (E–G) 
H2.35 hepatoma cells replete with SIRT3 or LacZ, but deficient for 
LRP130, were used. (E) SIRT3 was no longer sufficient to influence 
maximal respiration, using a Clark-type oxygen electrode (n = 6). How-
ever, control shRNA SIRT3 cells retained increased respiratory capac-
ity (see Supplemental Figure 6). Assessment of mitochondrial content 
was unchanged, as assessed by (F) MitoTracker Green FM or (G) 
mtDNA content (n = 3). (H–K) LRP130 liver-specific knockout (LRP130 
LKO) mice were used. Hepatic gene (H) and protein (I) expression 
(n = 4). (J) Effect of fasting on mitochondrially encoded genes in liver. 
(K) Effect of fasting on fasting-responsive genes in liver. Data are 
mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 2-way ANOVA, with 
(A, D, H, and K) or without (C and J) Bonferroni post-test, or 2-tailed 
unpaired Student’s t test (E–G).
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is required for fatty acid oxidation. In summary, SIRT3 activat-
ed mitochondrial transcription and increased OXPHOS. This 
action was dependent on LRP130, a regulator of mitochondrial 
transcription and OXPHOS.
SIRT3 deacetylates LRP130 in fasted liver and increases its transcrip-
tional activity. Given that nutrient deprivation induces mitochon-
drial SIRT3, we evaluated whether SIRT3 influences acetylation of 
LRP130 protein in fasted liver mitochondria. Compared with fed 
liver, LRP130 was deacetylated in fasted liver mitochondria, a state 
in which SIRT3 activity (and protein) was increased (Figure 7A). 
Supporting regulation by SIRT3, LRP130 was hyperacetylated in 
SIRT3-deficient mouse liver (Figure 7B). In accordance with cell-
autonomous control, NAD+ promoted deacetylation of LRP130 
in H2.35 cells replete with SIRT3 (Figure 7C). Buttressing these 
data, LRP130 coimmunoprecipitated with SIRT3 (Figure 7D), but 
failed to immunoprecipitate with SIRT5 (data not shown), anoth-
er — albeit less potent — deacetylase localized to mitochondria. 
To assess a functional interaction, we evaluated whether SIRT3 
deacetylates purified LRP130 protein. Since mitochondrial acety-
lases have not been characterized, we used CREB-binding protein 
(CBP) to acetylate purified LRP130 protein, an approach that is 
standard in the field (37, 38). In the presence of purified SIRT3 
protein, acetylated LRP130 C-terminal protein was robustly 
deacetylated by SIRT3 (Figure 7E). Similar, but less robust, results 
were obtained using N-terminal fragments of LRP130 (data not 
shown). Collectively, these data argue that SIRT3 deacetylates 
LRP130 in fasted liver. Finally, the conclusion that LRP130 is a 
bona fide target of SIRT3 was buttressed by a review of proteomic 
analyses (39–41), in which SIRT3 was found to be deficient in 
either cells or mouse liver (Supplemental Figure 9).
Next, we used mass spectrometry to map 17 lysine residues of 
LRP130 sensitive to deacetylation by SIRT3 (Figure 7F and Sup-
plemental Table 1). Sites with greater than 2-fold change were 
deemed positive. The mass spectrometry signal from the control 
reaction containing acetylated LRP130 protein was divided into 
the signal from the SIRT3 reaction. This ratio was subtracted from 
1, yielding the arbitrary metric of percent deacetylation.
To evaluate the genetic and functional implications of LRP130 
protein acetylation, we mutated 7 of 17 acetylated lysines to argi-
nine (referred to herein as LRP130-7KR; Figure 7F and Supple-
mental Table 1). By mutating a lysine to an arginine, a mutated 
site retains its positive charge and functionally mimics deacety-
lated protein. Similarly, we generated a 7KQ mutant of LRP130 
(LRP130-7KQ). Mutating a lysine to glutamine retains a neutral 
charge at the site and often mimics acetylated protein.
2 groups previously reported that LRP130 stimulates mitochon-
drial transcription (12, 42). In cell lysates, LRP130 interacted with 
both TFB2M and POLRMT (12), both of which comprise the basal 
Figure 7
During the fasted response, SIRT3 deacetylates LRP130 in liver mitochondria. (A) Representative immunoblot and protein quantification showing 
reduced acetylation of LRP130 (Ac-LRP130) in mitochondria isolated from fasted mouse liver (n = 3 experiments). (B) Immunoblot and protein 
quantification showing hyperacetylation of LRP130 in mitochondria isolated from liver deficient for SIRT3 (n = 4). (C) Immunoblot showing 
deacetylation of LRP130 in H2.35 cells stably expressing SIRT3 upon treatment with 500 μM NAD+. (D) SIRT3 and LRP130 coimmunoprecipi-
tated, using ectopically expressed SIRT3-FLAG protein and endogenous LRP130. (E) Using purified proteins, SIRT3 robustly deacetylated the C 
terminus of LRP130. Deacetylation of LRP130 was inhibited by 12.5 mM nicotinamide (NAM). Shown is 1 representative of 4 independent experi-
ments. Similar, but less robust, deacetylation was obtained for the N terminus of LRP130 (not shown). (F) Acetylated LRP130 fragments were 
incubated with control buffer or purified SIRT3 protein, then subjected to mass spectrometry. Lysines showing greater than 50% deacetylation by 
SIRT3 are graphed (gray and black bars). Percent deacetylation was calculated as 1 – (SIRT3 signal/control signal). 7 lysines were mutated to 
arginines (gray bars), generating LRP130-7KR, which mimics deacetylated protein. Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 
2-tailed unpaired Student’s t test (A and B).
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transcription machinery of mitochondria (15). We therefore rea-
soned that the acetylation status of LRP130 might influence its 
interaction with TFB2M and/or POLRMT. Because POLRMT and 
LRP130 migrate at similar molecular weights, we refined the level 
of interaction to aas 340–710 of POLRMT (Supplemental Fig-
ure 10). This enabled us to use a 1–710 aa fragment of POLRMT, 
which is easily distinguished from LRP130. We evaluated wheth-
er LRP130-7KR (which mimics deacetylated protein) differen-
tially interacts with either TFB2M or the 1–710 aa fragment of 
POLRMT. Compared with murine LRP130-WT, LRP130-7KR pref-
erentially interacted with POLRMT, whereas differential binding 
of TFB2M was less apparent (Figure 8, A and B).
Next, we evaluated whether LRP130-7KR and LRP130-7KQ exhib-
ited differential activity. We transiently expressed LRP130-WT or 
the murine LRP130 mutants in 293T cells deficient for endogenous 
human LRP130. We used this strategy to mitigate competition with 
endogenous LRP130 and to evaluate activity using physiologically rel-
evant levels of LRP130 protein. Although human and mouse LRP130 
share more than 75% homology at the protein level, the shRNA 
targeting human LRP130 mRNA does not target mouse Lrp130 
mRNA. Knockdown of human LRP130 in 293T cells and reconsti-
tution with murine LRP130 is shown in Supplemental Figures 11 
and 12. Endogenous SIRT3 activity was inhibited using 10 mM 
nicotinamide, a dose previously shown to impair NAD+-dependent 
Figure 8
LRP130-7KR stimulates mitochondrial transcription and promotes OXPHOS. (A) LRP130-7KR, which mimics deacetylated protein, showed 
increased affinity for aas 1–710 of POLRMT, a fragment that contains the catalytic domain. See Supplemental Figure 10 for more detailed map-
ping. (B) In contrast, compared with LRP130-WT, LRP130-7KR showed no differential affinity for TFB2M. (C, D, and F) Using 293T cells, endog-
enous human LRP130 was knocked down >95%, then reconstituted with murine LRP130-WT or LRP130-7KR (see Supplemental Figure 11). The 
shRNA targeting human LRP130 does not target mouse Lrp130 (not shown). Endogenous NAD+-dependent sirtuin activity was inhibited with 
10 mM nicotinamide for 16 hours. LRP130-7KR had greater (C) mitochondrially encoded gene expression (n = 3), (D) mitochondrial transcription 
(n = 3), and (F) maximal respiration (n = 5) versus LRP130-WT. (E) Immunoblot showing similar levels of ectopically expressed LRP130-WT and 
LRP130-7KR. See Supplemental Figure 11 for total LRP130 protein. Data are mean ± SEM. *P < 0.05, ***P < 0.001, 2-way ANOVA (C and D) or 
2-tailed unpaired Student’s t test (F).
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sirtuin activity in 293T cells. Compared with LRP130-WT, LRP130-
7KR exhibited greater activity, as assessed by mitochondrial gene 
expression, mitochondrial transcription, and oxygen consumption 
(Figure 8, C, D, and F). The level of ectopically expressed LRP130 
protein was comparable (Figure 8E). Interestingly, the effect on tran-
scription was much greater than that on respiration, indicative of 
either a saturation effect or limitations of our experimental system. 
In contrast, LRP130-7KQ did not increase mitochondrially encod-
ed gene expression (Supplemental Figure 12), which suggests that 
deacetylation of LRP130 (as reflected by LRP130-7KR) increases its 
activity. Since SIRT3-dependent pathways were inhibited by nicotin-
amide, in terms of mitochondrial transcription and OXPHOS, these 
data indicate that LRP130 is a crucial mediator of SIRT3 action. 
Taken together, our results imply that deacetylation of LRP130 by 
SIRT3 enhances the activity of LRP130, which in turn stimulates 
mitochondrial transcription and OXPHOS.
In summary, we have identified a mechanism whereby nutri-
ent sensing by SIRT3 induces mitochondrial transcription and 
enhances OXPHOS via LRP130 (Figure 9). Moreover, our present 
findings indicate that SIRT3 coordinates activation of enzyme sys-
tems involved in fatty acid oxidation as well as OXPHOS. In fasted 
liver, our data support a model whereby activation of mitochon-
drial transcription increases OXPHOS capacity, and this enhanced 
bioenergetic efficiency would be predicted to support increased 
substrate oxidation.
Discussion
Here, we identified an unanticipated link between nutrient 
sensing and mitochondrial transcription that was critical for 
fasting-mediated induction of OXPHOS. In fasted liver, ATP 
synthesis is accompanied by a 20% increase in oxygen con-
sumption (43, 44), enabling ATP-dependent processes such as 
gluconeogenesis and ureagenesis. While increases in nutrient 
flux and oxidation are essential, OXPHOS capacity is critical 
factor as well. We showed here that SIRT3 deacetylated LRP130 
during the fasted response. Once deacetylated, LRP130 stimu-
lated mitochondrial transcription to increase mitochondrially 
encoded gene expression and OPXHOS, independent of de novo 
mitochondrial biogenesis. In fasted liver, SIRT3 protein has 
previously been shown to plateau at 18–24 hours and activate 
enzyme systems involved in fatty acid oxidation, culminating in 
greater β-oxidation of fatty acids (5). At 24 hours, we observed 
SIRT3-mediated deacetylation of LRP130. We therefore pro-
pose that SIRT3 couples enhanced β-oxidation of fatty acids to 
increase OXPHOS capacity via LRP130. Presumably, this strat-
egy permits metabolic matching between 2 enzyme systems that 
are linked by coenzyme cycling: shuttling of NAD+ and NADH 
between fatty oxidative pathways and OXPHOS.
Governed by SIRT3 and LRP130, nutrient control of OXPHOS 
via mitochondrial transcription is a simple, yet elegant, model. 
Regarding control of OXPHOS, prior studies on SIRT3 impli-
cated modifications of various subunits of the electron transport 
chain or alterations in mitochondrial content. In SIRT3-defi-
cient cell lines, respiration is impaired and there is hyperacety-
lation of several respiratory complexes, including complex I (7, 
10), succinate dehydrogenase (9), and complexes III and V (10). 
The stabilization of several nuclear encoded subunits may be 
related to their acetylation status, which might explain the dif-
ferential regulation of complex activity previously reported by 
others (7). One limitation to interpreting these studies is that 
Figure 9
In fasted liver, the transcription machinery of mitochondria sense nutrient deprivation via SIRT3, culminating in enhanced energy metabolism. In 
liver, SIRT3 is induced by nutrient deprivation. Specifically, glucagon, which activates cAMP signaling, increases SIRT3 activity, perhaps by indirectly 
increasing mitochondrial NAD+ levels. LRP130 is then deacetylated and activated by SIRT3, which strengthens the LRP130-POLRMT interaction. 
This culminates in increased mitochondrial transcription and attendant OXPHOS. Presumably, processes dependent on OXPHOS — fatty acid oxida-
tion, gluconeogenesis, ketogenesis, and ureagenesis — are augmented by increased respiratory capacity. To simplify the model, deacetylation of 
enzymes involved in fatty acid oxidation and ketogenesis, as well as SIRT3 action on individual OXPHOS subunits, are not illustrated.
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LRP130 is sufficient to stimulate mitochondrial transcription and 
attendant OXPHOS, we cannot definitely exclude parallel deacety-
lation and activation of the basal transcription machinery. TFAM, 
a regulator of both mitochondrial transcription and replication, 
is acetylated in cells and mouse liver (40, 48), which is dependent 
on SIRT3 (40). After caloric restriction, there is a slight decrease 
in acetylation of TFAM; however, the functional and biological 
significance of this slight change is unknown, as an acetylation 
mutant was not evaluated (40). Although interesting and impor-
tant, evaluating the basal transcription machinery in the context 
of biology will prove challenging, since ablation of its components 
completely interdicts OXPHOS, while in our study, ectopic expres-
sion of either TFB2M or POLRMT paradoxically attenuated mito-
chondrially encoded gene expression. This implies a finely tuned 
balance, limiting the tools and approaches available to decipher 
mechanisms. In terms of mitochondrially encoded gene expres-
sion, ablation of LRP130 still permitted some basal transcription, 
while its ectopic expression induced transcription. We therefore 
believe LRP130 is uniquely poised to specifically evaluate mito-
chondrial transcription and OXPHOS.
What are the broader questions pertinent to integrative physi-
ology and disease? An increasing number of reports suggests that 
a mismatch between nutrient flux and oxidative capacity pro-
motes and/or exacerbates insulin resistance (1–3). In human and 
mouse studies, increased fatty acid flux in the setting of impaired 
tricarboxylic acid and/or OXPHOS activity is associated with 
insulin resistance (1, 3, 49, 50). SIRT3 activity is impaired in mice 
fed a high-fat diet for 16–24 weeks that develop insulin resistance 
(51). Additionally, ablation of SIRT3 leads to metabolic syn-
drome (10, 11), suggestive of a causal role. Although the notion 
is speculative, a decline in SIRT3 activity might lead to impaired 
OXPHOS in liver and exacerbate insulin resistance. One addi-
tional question to consider is whether pathways involved in 
OXPHOS and fatty acid oxidation exhibit differential sensitiv-
ity to SIRT3 activity, which might produce a mismatch between 
fatty acid oxidation and OXPHOS.
In conclusion, induction of SIRT3 by fasting induced OXPHOS 
by increasing mitochondrial gene expression. Upon deacety-
lation by SIRT3, LRP130 induced mitochondrial transcription, 
culminating in greater OXPHOS capacity. We hypothesize that 
greater OXPHOS capacity improves mitochondrial bioenergetic 
efficiency, thereby supporting parallel and downstream bio-
chemical pathways.
Methods
Cell culture and animal experiments
Stable transduction of H2.35 cells with SIRT3 or LacZ was achieved using 
pQCXIP vectors (Clontech), as previously described (12). H2.35 cells sta-
bly expressing SIRT3 or LacZ were treated with 500 μM NAD+ 16 hours 
prior to harvest. Knockdown of murine Lrp130 was performed as previ-
ously described (35, 36). The shRNA sequence targeted against human 
LRP130 was 5′-ATGTGAGTCACTATAATGCT-3′. Primary hepatocytes 
were isolated from mice as previously described (52). Briefly, approximately 
400,000 hepatocytes were seeded per well of a 6-well plate and infected 
with adenovirus encoding the gene of interest. Virus sufficient to produce 
a multiplicity of infection of 400 in AD-293 cells (Stratagene, catalog no. 
240085) was used to infect 400,000 hepatocytes. After 16 hours, virus was 
removed and replaced with fresh medium. Hepatocytes were further incu-
bated for 20 hours, after which cells were harvested. For transduction of 
mutant subunits that mimic acetylated or deacetylated protein 
were not evaluated. It is therefore difficult to discern the func-
tional relevance of these modifications.
In liver, the salutary actions of SIRT3 on OXPHOS do not 
require an increase in mitochondrial content. This is in contrast 
to immortalized, brown fat–like HIB1B cells, in which ectopic 
expression of SIRT3 was associated with increased Pgc1a, mito-
chondrial biogenesis, and concomitant OXPHOS (45). Using 
mouse models and cell culture, we did not observe changes in 
mitochondrial mass due to SIRT3, which suggests that the effect 
of SIRT3 on mitochondrial mass is restricted to certain cellular 
contexts. Notably, our results indicate a prominent role for SIRT3 
in mitochondrial transcription, which promotes OXPHOS. Ecto-
pic expression of SIRT3 in cells deficient for LRP130 protein failed 
to induce OXPHOS or mitochondrially encoded genes. Similarly, 
in liver deficient for LRP130, fasting failed to induce mitochondri-
ally encoded gene expression. These data suggest that mechanisms 
independent of LRP130 are either trivial or operate downstream 
of mitochondrial transcription. For instance, in LRP130-deficient 
cells, reduction of mitochondrially encoded genes is associated 
with reduced OXPHOS subunits (12, 35, 36, 46), attenuation that 
might offset deacetylation of individual OXPHOS subunits. If 
normal mitochondrially encoded gene expression is a prerequisite 
for SIRT3-mediated activation of individual OXPHOS subunits, 
then ablation of LRP130 would abrogate any downstream effect. 
Additionally, LRP130 might influence factors involved in mito-
chondrial transcription. In our studies, neither POLRMT nor 
TFB2M, which comprise the initiation complex, were unchanged. 
Even so, we cannot exclude the possibility that other factors 
involved in transcription are not secondarily perturbed. Never-
theless, LRP130-deficient cells still retained some OXPHOS com-
plexes, albeit less than those of wild-type cells. If activation of indi-
vidual OXPHOS subunits were a predominant action of SIRT3, 
one would anticipate some enhancement of OXPHOS even in the 
absence of LRP130, a finding we failed to observe. Additionally, 
SIRT3 regulates several hundred mitochondrial proteins. Indeed, 
in other cellular systems, variegated actions of SIRT3 are not readi-
ly intuitive (47); hence, without further investigation, our findings 
predominantly relate to the fasted response. Nonetheless, even 
when NAD+-dependent sirtuins were pharmacologically inhibit-
ed, LRP130-7KR had greater activity in terms of transcription and 
OXPHOS capacity. This indicates that isolated deacetylation of 
LRP130 is sufficient to stimulate mitochondrial transcription and 
OXPHOS. Although we cannot exclude direct effects of acetylation 
on OXPHOS complexes per se, our data highlight a significant 
pathway involving mitochondrial transcription and attendant 
OXPHOS mediated by SIRT3 and LRP130.
Our results indicate that SIRT3 influences mitochondrial tran-
scription via LRP130. In concert with prior reports by us and 
others (12, 42), these data further support a role for LRP130 in 
the control of mitochondrial transcription. Some studies have 
reported that LRP130 stabilizes mitochondrial transcripts; how-
ever, such a role for LRP130 in SIRT3-mediated control of mito-
chondrial gene expression was not supported here. As stated ear-
lier, the LRP130-7KR mutant increased mitochondrially encoded 
transcripts, even when endogenous SIRT3 was inhibited. This 
suggests that deacetylation of basal mitochondrial transcription is 
not strictly required. Thus far, no differential acetylation has been 
reported for POLRMT or TFB2M, which collectively constitute the 
initiation complex. While our results suggest that deacetylation of 
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mented with 500 μM NAD+. The 0-hour time point was defined as 9 am 
on day 2. At the 1- and 2-hour time points, cells were washed with PBS, 
after which medium containing 20 mM uridine (Sigma-Aldrich, catalog 
no. U3003) was used to chase the 4sU label. RNA harvesting and process-
ing proceeded as described above.
Immunopurification of acetylated proteins and detection of 
acetylated LRP130 protein
Acetylated proteins were immunopurified as previously described (54). 
Briefly, crude mitochondria were extracted from approximately 400 mg 
of mouse liver, then frozen on liquid nitrogen. The frozen mitochondrial 
pellet, about 100 μl volume, was lysed in 500 μl FLAG lysis buffer (50 mM 
Tris-Cl pH 7.8, 137 mM NaCl, 10 mM NaF, 1 mM EDTA, 1% Triton X-100, 
0.2% sarkosyl, 10% glycerol) supplemented with 10 μM TSA and 5 mM 
nicotinamide. The typical lysate yielded a protein concentration of about 
5 mg/ml. 2–10 mg mitochondrial lysate was incubated with 30 μl anti–
acetylated lysine antibody–conjugated beads (Immunechem, catalog no. 
ICP0388) at 4°C overnight. The beads were washed with FLAG lysis buffer 
4 times, 1 minute per wash, at room temperature. Acetylated protein was 
eluted with 49 μl freshly prepared glycine (0.1 M, pH 2.5) for 5–10 min-
utes at room temperature. 1 elution usually proved sufficient, yielding the 
highest protein concentration. 1 μl saturated Tris, prepared by dissolving 
Tris base in ddH2O until saturated, was added to the eluate to achieve a 
pH of 7.0. To detect acetylated LRP130 protein, immunoenriched acety-
lated fractions were immunoblotted for LRP130 using anti-LRP130 rabbit 
polyclonal sera, as previously reported (12).
qPCR of mtDNA content and RT-qPCR
To isolate total DNA, approximately 20 mg frozen liver was lysed in 200 μl 
tissue lysis buffer (50 mM Tris-Cl pH 7.5, 50 mM EDTA pH 8.0, 100 mM 
NaCl, 1% Triton X-100, 5 mM DTT, 100 mg/ml proteinase K) at 56°C over-
night. The lysate was extracted once with phenol/chloroform, after which 
the aqueous phase was precipitated with 0.1 volumes of 3 M sodium acetate 
(pH 5.2) and 2.5 volumes of 100% ethanol. Total DNA was quantified using 
Quant-iT Picogreen dsDNA assay kit (Invitrogen). In a qPCR reaction volume 
of 15 μl, 400 pg total DNA was used to quantify mtDNA content. Showing 
strong agreement, 4 mtDNA genes — ND1, ND6, ATP6, and COX1 — were used 
to quantify mtDNA content. 18S and 28S rRNA served as nuclear reference 
genes (unless otherwise indicated). In addition, Tbp served as a reference gene 
(unless otherwise indicated); however, 10 ng total DNA in a reaction volume 
of 15 μl was used. For RT-qPCR, total RNA was isolated and processed as pre-
viously described (12). See Supplemental Tables 2 and 3 for primers.
Citrate synthase activity in whole liver homogenate
Citrate synthase assay was performed as previously described (55), with 
slight modifications. 30 mg frozen liver was placed in 300 μl RIPA buffer 
(50 mM Tris-Cl pH 7.4, 150 mM NaCl, 5 mM EDTA pH 8.0, 0.1% SDS, 1% 
sodium deoxycholate, 1% NP40) supplemented with PMSF and protease 
inhibitor cocktail (Sigma-Aldrich), followed by homogenization using a 
bead-mill homogenizer (Qiagen GmbH) at 25 Hz for 120 seconds. The 
liver homogenate was incubated on ice for 30 minutes, then centrifuged at 
16,100 g for 10 minutes at 4°C. The protein concentration of the cleared 
homogenate was determined using a BCA kit (Thermo Scientific). 10 μg 
protein was loaded in citrate synthase assay buffer (100 mM Tris-Cl pH 
8.0, 0.1 mM DTNB, 0.1 mM acetyl-CoA). The reaction was started by add-
ing 0.25 mM freshly prepared oxaloacetate. A blank sample contained all 
reagents except liver homogenate. The increase in absorbance due to the 
formation of 5-thio-2-nitrobenzene anion at 412 nm was measured every 
30 seconds for 15 minutes at room temperature. The activity of citrate syn-
thase was expressed as the blank-corrected slope of the absorbance versus 
liver, 8 × 109 live adenoviral particles were tail vein injected into C57BL/6 
mice on day 0 in 100 μl PBS. On day 5, liver tissue was harvested. Mice were 
maintained in 12-hour light/12-hour dark cycle.
Lrp130flox/flox mice, which harbor loxP sites flanking exons 3 and 4 of 
Lrp130, were generated by the University of Massachusetts Medical School 
Transgenic Animal Modeling Core from KOMP ES cell clone CSD33081. 
Prior to experimentation, mice were backcrossed for at least 8 generations 
onto the C57BL/6 background. Lrp130flox/flox mice and wild-type controls 
aged 8–12 weeks were infected with AAV-Cre at 1.0 × 1011 GC/mouse in 
100 μl PBS. The vector for liver-specific cre recombinase driven by the human 
thyroxine-binding globulin promoter was packaged in adeno-associated 
virus by the Viral Vector Core of the University of Massachusetts Medical 
School as previously described (53). 3 weeks after injection, mice were singly 
housed beginning at 10 am for exactly 24 hours in a fed or fasted state, after 
which they were euthanized for protein and genetic studies. Pgc1aflox/flox 
mice (The Jackson Laboratory, stock no. 009666) were injected with AAV-
Cre as described above. 3 weeks after infection, primary hepatocytes were 
isolated for experimentation.
Assessment of mitochondrial mass using MitoTracker Green FM
Mitochondrial mass was evaluated by flow cytometric analysis of cells 
stained with MitoTracker Green FM (Invitrogen). Briefly, cells were stained 
with Mitotracker Green FM at 100 nM for 30 minutes at 37°C. Cells were 
rinsed with PBS, trypsinized, and centrifuged at 130 g for 4 minutes. Cell 
pellets were resuspended in PBS containing 1% FBS for FACS. To quantify 
mitochondrial mass, 20,000 live cell counts were gated. Since MitoTracker 
Green FM is excited at 490 nm and emits at 516 nm, the FITC channel 
(excitation at 494 nm, emission at 520 nm) was used to detect signal.
Quantification of transcription and RNA degradation in whole cells
4sU was used to quantify transcription and RNA degradation as previ-
ously described (32), with some modifications. For transcription assays, 
1.77 × 106 H2.35 cells stably expressing LacZ or SIRT3 were plated in 10-cm 
dishes and allowed to attach overnight. Cells were treated with 500 μM 
NAD+ for 16 hours and labeled with 2 mM 4sU (Sigma-Aldrich, catalog no. 
T4509) for 15 minutes at 37°C. RNA was isolated from cells using TRIzol 
and Qiagen’s RNeasy mini kit. 50 μg RNA was labeled with EZ-link Biotin-
HPDP for 1.5 hours at room temperature. Unbound Biotin-HPDP was 
removed by chloroform/isoamylalcohol (24:1) extraction at 16,000 g for 5 
minutes. A 1:10 volume of 5 M NaCl and an equal volume of isopropanol 
were added. Precipitated RNA was pelleted at 16,100 g for 20 minutes at 
4°C. The pellet was washed with 75% ethanol and again pelleted at 16,100 g 
for 5 minutes at 4°C. The pellet was resuspended in 100 μl TE buffer 
(10 mM Tris-Cl pH 8.0, 1 mM EDTA). RNA samples were denatured at 
65°C for 10 minutes, then rapidly cooled on ice for 5 minutes. Subse-
quently, denatured biotinylated RNA was captured using Dynabeads 
M-270 streptavidin (Invitrogen) with rotation at room temperature for 15 
minutes. Beads were washed 3 times with 55°C wash buffer (100 mM Tris 
pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1% Tween-20), followed by 3 washes at 
room temperature. Biotin-labeled RNA was eluted with 100 mM DTT by 
rotating at room temperature for 10 minutes. De novo transcripts were 
cleaned up using Qiagen’s RNeasy mini kit. Recovered transcripts were 
quantified using Ribogreen (Invitrogen). Approximately 120 ng RNA was 
used for reverse transcription and subsequent qPCR (RT-qPCR). To assess 
specificity, a reaction containing no 4sU label was performed in parallel. In 
general, 4sU transcripts were enriched more than 60-fold.
For RNA degradation studies, on day 0 at 9 am, H2.35 cells stably express-
ing LacZ or SIRT3 were plated at a density of 2.8 × 105 cells/well of a 6-well 
plate. On day 1 at 9 am, cells were labeled with 0.1 mM 4sU, labeling that 
continued for 24 hours. On day 1 at 5 pm, labeling medium was supple-
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For purification of CBP-GST fusion protein, E. coli Rosetta (DE3) cells 
were transformed with plasmid encoding CBP-HAT-GST (pGEX-4T1-CBP-
HAT). Bacteria were cultured in 6 ml LB medium containing carbencil-
lin (100 μg/ml). After overnight culture at 37°C with vigorous shaking, 
1,000 ml fresh LB medium was inoculated, and bacteria were allowed to 
grow for 3–5 hours, until OD600 reached 0.4–0.6. Expression of GST-CBP 
fusion protein was induced with overnight at room temperature using 
0.5 mM IPTG. Bacteria were harvested by centrifugation at 1,500 g for 15 
minutes. The pellet was resuspended in 10–15 ml ice-cold PBS and an equal 
volume of BC100 buffer. Following sonication, Triton X-100 was added 
until reaching a final concentration of 1%. Lysates were clarified at 13,300 g 
for 30 minutes. The supernatant was transferred to a new tube. 100 μl 
glutathione agarose beads (Pierce, catalog no. 16110) was added to the 
supernatant and incubated at 4°C overnight. The beads were washed 3 
times with 20 ml BC500 (500 mM NaCl, 20% glycerol, 20 mM Tris-Cl pH 
7.9, 0.1% NP-40) and 2 times with 20 ml BC100. GST-tagged CBP protein 
was eluted for 2 hours at 4°C with 20 mM reduced glutathione (Thermo 
Scientific, catalog no. 78259).
In vitro acetylation and deacetylation assays
Acetylation reactions of 10 μl volume contained 50 mM HEPES (pH 8.0), 
10% glycerol, 1 mM DTT, 1 mM PMSF, 10 mM sodium butyrate, 100 μM 
acetyl-CoA, 2 μg LRP130 purified protein, and 100 ng CBP-HAT domain 
protein (1,319–1,710 aa). The reaction mixture was incubated at 30°C for 
1.5 hours. Subsequently, an equal volume of 2× LDS loading buffer was 
added, and the reactions were analyzed by immunoblotting overnight at 
4°C with anti–acetylated lysine antibody (Cell Signaling, catalog no. 9441).
For in vitro deacetylation assay, acetylated LRP130 protein was recovered 
by binding to Ni-NTA beads (Qiagen, catalog no. 30410) and washed 3–4 
times with 1 ml wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM 
imidazole, pH 8.0), 1 minute per wash, at room temperature. Acetylated 
LRP130 protein was eluted with 50 μl of 250 mM imidazole at 4°C for 2 
hours. The elution buffer was changed to BC100 using a NucAway spin 
column (Invitrogen). Deacetylation was performed in a 20-μl reaction con-
taining approximately 1 μg acetylated LRP130 protein, 2 μl purified SIRT3 
(Cyclex kit, catalog no. CY-1153), and 500 μM NAD+. The reactions were 
incubated at 30°C for 1.5 hours in a buffer containing 50 mM Tris-HCl 
(pH 9.0), 50 mM NaCl, 4 mM MgCl2, 0.5 mM DTT, 0.2 mM PMSF, 0.02% 
NP-40, and 5% glycerol. Subsequently, the reaction was stopped by add-
ing 4× LDS loading buffer, and the reactions were analyzed by immuno-
blotting overnight at 4°C using anti–acetylated lysine antibody (Cell Sig-
naling, catalog no. 9441).
Identification of peptides using tandem mass spectrometry
Mass spectrometry studies were performed at the Proteomics and Mass 
Spectrometry Facility of University of Massachusetts Medical School, 
as previously reported (56). In brief, silver stained gel bands were rinsed 
in water and briefly incubated with ammonium bicarbonate (100 mM). 
Gel bands were next destained with a 1:1 ratio of potassium ferricyanide 
(30 mM) and sodium thiosulfate (100 mM), and transferred to new tubes 
containing 1 ml water for 1 hour. After removal of the water, gel slices 
were subjected to addition of 50 μl of 250 mM ammonium bicarbonate, 
reduced with 5 μl of 45 mM DTT for 30 minutes at 50°C, and then alkyl-
ated with 5 μl of 100 mM iodoacetamide for 30 minutes at room tem-
perature. The slices were then washed twice with 1 ml water, incubated 
in a 1:1 solution of 50 mM ammonium bicarbonate/acetonitrile at room 
temperature for 1 hour, soaked in 200 μl acetonitrile, removed, and 
dried in a SpeedVac. Samples were then digested with 50 μl of 2 ng/μl 
trypsin (Sigma-Aldrich) in 0.01% ProteaseMAX Surfactant (Promega) 
in 50 mM ammonium bicarbonate at 37°C for 21 hours. The superna-
time plot within the linear range. Activity was presented as absorbance 
units per second per milligram protein (AU/s•mg protein), obtained by 
multiplying AU/s•10 μg protein by 1,000 μg/mg protein.
Cloning and construction of LRP130-7KR
Lysine-to-arginine (KR) mutations were made using a Quick Change II 
XL site-directed mutagenesis kit (Stratagene, catalog no. 200521). First, a 
5KR mutant (K1036R, K1059R, K1250R, K1348R, and K1355R) was gener-
ated by serially mutating a C-terminal fragment of LRP130 (1,011–1,392 
aa) contained in the pET30a vector. After PCR amplification, the mutat-
ed fragment was digested with BlpI/PacI and ligated into the BlpI/PacI 
site of a pQCXIP vector encoding full-length murine LRP130. Second, a 
2KR mutant (K225R and K452R) was generated by serially mutating an 
N-terminal fragment of LRP130 (60–1,010 aa) contained in the pET30a 
vector. After PCR amplification, the fragment was digested with BspE1 and 
ligated into the BspE1 site of LRP130-5KR/pQCXIP, yielding LRP130-7KR 
(K225R, K452R, K1036R, K1059R, K1250R, K1348R, and K1355R). Con-
firmation of mutations was assessed using Sanger method sequencing.
Cloning and construction of LRP130-7KQ
Lysine-to-glutamine (KQ) mutations were made using a Quick Change II 
XL site-directed mutagenesis kit (Stratagene, catalog no. 200521). First, a 
2KQ mutant (K1036Q and K1250Q) was generated by serially mutating a 
C-terminal fragment of LRP130 (1,011–1,392 aa) contained in the pET30a 
vector. After PCR amplification, the mutated fragment was digested with 
BlpI/PacI and ligated into the BlpI/PacI site of a pQCXIP vector encoding 
full-length murine LRP130. Second, we removed a segment of the above 
LRP130-2KQ/pQCXIP plasmid by digestion with SnaBI, yielding the 7.6-kb 
truncation product LRP130-2KQ/ΔpQCXIP. Then, 3 additional C-terminal 
KQ mutations (K1059Q, K1348Q, and K1355Q) were generated by serially 
mutating the LRP130-2KQ/ΔpQCXIP vector. This mutated fragment was 
digested with XhoI/PacI and reinserted into a similarly digested, full-length 
LRP130/pQCXIP vector, producing a 5KQ mutant of LRP130. A third 
2KQ mutant (K225Q and K452Q) was generated by serially mutating an 
N-terminal fragment of LRP130 (60–1,010 aa) contained in the pET30a 
vector. After PCR amplification, the fragment was digested with BspE1 and 
ligated into the BspE1 site of LRP130-5KQ/pQCXIP, yielding LRP130-7KQ 
(K225Q, K452Q, K1036Q, K1059Q, K1250Q, K1348Q, and K1355Q). Con-
firmation of mutations was assessed using Sanger sequencing.
Purification of recombinant proteins
For purification of LRP130 fragments contained in pET30a, a single colony 
was cultured in 6 ml kanamycin LB media at 37°C overnight. 5 ml of over-
night culture was transferred into 100 ml of LB media and shaken at 37°C 
for 3 hours until OD600 was about 0.4. The culture was then induced with 
1 mM IPTG for 5 hours at 37°C. Bacteria were harvested by centrifugation 
at 1,500 g for 15 minutes, and the pellet was frozen at –80°C until further 
processing. After thawing, the pellet was resuspended in 10 ml lysis buffer 
(50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 0.5 mM PMSF, pH 8.0). 
1 mg/ml lysozyme and 100 μl of 10% Triton X-100 was added into the lysis 
buffer and incubated at 37°C for 10 minutes. Bacterial DNA was sheared 
by sonicating (Sonic Dismemberator 60, Fisher, maximum output) twice 
for 10 seconds. Cell debris was pelleted at 9,300 g for 20 minutes at 4°C. 
100 μl Ni-NTA beads were added to the supernatant and incubated at 4°C 
overnight. The beads were washed 3–4 times with 1 ml wash buffer (50 mM 
NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0), 1 minute each, at 
room temperature. His-tagged LRP130 protein was eluted 2 hours at 4°C 
with elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole). 
The buffer was exchanged to BC100 (100 mM NaCl, 20% glycerol, 20 mM 
Tris-Cl pH 7.9, 0.1% NP-40) using a NucAway spin column (Invitrogen).
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  (Equation 1)
Derivation. Conditioning on the peptides identified in Study A induces a 
separation of the peptides in Study B into 2 groups: the a peptides identified 
in Study A and the N – a peptides not identified in Study A. If the 2 stud-
ies identify exactly c peptides in common, Study B must identify c peptides 
among the a peptides and its remaining b – c peptides among the N – a pep-
tides. The number of ways in which this can occur is the product of the bino-
mial coefficients in the numerator. The total number of ways in which Study 
B can identify b peptides among the N is equal to the binomial coefficient in 
the denominator. This conditional probability applies to each of the possible 
sets of a peptides that Study A could identify. Because those sets are equally 
likely, the conditional probability is also the unconditional probability.
Assumptions. The application of the probabilities assumes there are 102 
potentially acetylatable lysine residues in LRP130 and that, if acetylated, 
each residue would have equal probability of detection by mass spectrom-
etry. It also assumes that mass spectrometry of LRP130 protein approach-
es 100% for each study. Because these conditions may not hold for every 
study, the probabilities are approximations.
Domain mapping and in vitro binding assay
Truncated mouse POLRMT clones expressing aas 1–340, 1–500, 1–650, and 
1–710 were each generated by PCR. The products of these reactions were 
digested with BamHI and XbaI, then ligated in frame into pcDNA3.1 myc 
His B plasmid. Clones containing full-length and truncated POLRMT were 
subjected to in vitro transcription/translation using a TnT kit (Promega, cat-
alog no. L4610). Full-length mouse LRP130 fused with an S-tag was immo-
bilized on S-protein agarose (Novagen, catalog no. 69704), then washed with 
25 mM HEPES and 0.125% Tween20 containing protease inhibitors. The 
translated products were subsequently treated with DNaseI and RNase for 
10 minutes at room temperature and centrifuged for 10 minutes at 15,700 g 
at 4°C. The supernatants were incubated with immobilized S-tag LRP130 
agarose. After incubation for 2 hours at 4°C, complexes were extensively 
washed with 25 mM HEPES, 0.125% Tween-20, and 0.125 M KCl, and c-myc 
was detected by immunoblotting.
Cellular respiration, complex activity, and isolation of mitochondria
Cellular respiration (12, 35), isolation of mitochondria (12, 35, 36), com-
plex activity (12), and fractionation of mitochondria by alkaline treatment 
(57) were performed as previously described.
Statistics
2-tailed Student’s t tests were used to analyze complex activity, mito-
chondrial content (using measures of mtDNA or fluorescence), protein 
quantification, and cellular respiration data. P values less than 0.05 were 
considered significant. 2-way ANOVA was used to assess differences in 
gene expression. Because mitochondrially encoded genes are transcribed 
as long polycistronic transcripts and thus tightly coordinated as a “gene 
set,” we evaluated the entire set using a 2-way ANOVA, reporting a P value 
comparing differences among various groups (or treatments). P values less 
than 0.05 were considered significant. In contrast, nuclear-encoded genes 
were subjected to post-hoc analyses (as indicated in the figure legends), 
since they are not polycistronic genes that do not necessarily fit into a 
specific gene set. For these studies, Bonferroni-corrected post-tests were 
implemented using a multiple comparison–adjusted α. All analyses were 
conducted using GraphPad Prism version 6.00.
tant of each sample was then removed and placed in a separate 0.5-ml 
tube, and each slice was further extracted with 100 μl acetonitrile/1% 
(v/v) formic acid (4:1), combined with respective supernatants of each 
sample, taken to dryness in a SpeedVac, and reconstituted in 20 μl 
of 0.1% TFA. LC-MS/MS analysis was done on a LTQ Orbitrap Velos 
mass spectrometer (Thermo Scientific) as previously reported (56), with 
the exception of using a 90-minute gradient for peptide elution. Raw 
data files were processed with either Mascot Distiller (Matrix Science) 
or Extract_MSN (Thermo Scientific), searched against the SwissProt 
database using the Mascot Search engine (Matrix Science). In brief, par-
ent mass tolerances were set to 10 ppm, while fragment mass tolerances 
were set to 0.5 Da. Full tryptic specificity with 2 missed cleavages was 
used, and variable modifications of acetylation (protein N-term, lysine), 
pyro-glutamination (N-term glutamine), oxidation (methionine), and 
carbamidomethylation (cysteine) were considered. Further peptide 
annotation was achieved using Scaffold (Proteome Software), while rela-
tive quantification of acetylated peptides was performed using ProteoIQ 
(Nusep Inc.). Spectra of acetylated peptides were manually inspected to 
further validate assignments.
Metabolic labeling of mitochondrial proteins
Mouse primary hepatocytes were isolated as previously described (36). 
Cells were seeded in 6-well plates at 4.5 × 105 cells/well. After 16 hours, 
cells were treated with vehicle or 20 nM glucagon (Bachem) for 24 hours 
in starvation media (DMEM, 0.2% BSA, 2 mM sodium pyruvate). Cells 
were pretreated with 100 μg/ml cycloheximide (Sigma-Aldrich) and/or 
100 μg/ml chloramphenicol (Sigma-Aldrich) as indicated for 10 minutes 
in methionine and cysteine-free starvation media containing vehicle or 
glucagon. Cells were then labeled with [35S]-methionine and [35S]-cysteine 
(50 μCi/ml, PerkinElmer) for 60 minutes and chased for 10 minutes in 
regular DMEM. Cells were washed with PBS twice and lysed in RIPA buffer 
supplemented with protease inhibitor cocktail (Sigma-Aldrich), followed 
by 3 freeze-thaw cycles. Lysates were cleared by centrifugation at 16,100 g 
for 10 minutes at 4°C. Protein concentration was determined by BCA 
assay (Thermo Scientific). 80 μg of protein (20 μg for total translation) 
were separated on a 15% polyacrylamide gel at 50 mA. The gel was fixed 
and stained using colloidal blue staining kit (Invitrogen) to confirm equal 
protein loading. The gel was then dried at 70°C for 3 hours and exposed 
to a Biomax MR film (Carestream Health). Radioactivity in 5 μl of lysates 
was quantified using a liquid scintillation counter (Beckman Coulter) and 
normalized to protein concentration.
Palmitate oxidation assay
Palmitate oxidation was performed as previously described (12). Briefly, 
H2.35 mouse hepatoma cells were incubated in starvation medium (1% 
BSA, 25 mM HEPES, 1 mM sodium pyruvate in DMEM) in the presence of 
0.5 mM NAD+ for 16 hours. Cells were then incubated for 2 hours in pre-
incubation medium (1% BSA, 25 mM HEPES, 0.25 mM sodium palmitate, 
0.5 mM carnitine in DMEM), and subsequently, 0.5 μCi/well of 14C-pal-
mitate was added for 90 minutes. The plate was frozen in liquid nitrogen, 
and 250 μl perchloric acid was added to each well. Filter paper moistened 
with 3N NaOH was immediately placed over each well and released CO2.
Comparison of acetylated LRP130 sites across studies
To estimate the probability that, by chance, 2 studies (Study A and Study 
B) would identify a given number of acetylated residues in common, we 
used the hypergeometric distribution. If, of a total N acetylated LRP130 
peptides, Study A identified a peptides and Study B identified b peptides, 
the probability that the sets of peptides identified by the 2 studies would 
have exactly c peptides in common, 0 ≤ c ≤ min{a,b}, is as follows.
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